Overview
HealthEquity, Inc., based in the United States, operates predominantly within the health care sector, specifically focusing on technology-driven services that facilitate health savings accounts (HSAs) and other health financial services. Since its inception, the company has expanded its offerings to include reimbursement accounts such as FSAs, HRAs, as well as VEBA, and commuter benefits. A key project for HealthEquity involves integrating technology to simplify the management and accessibility of health accounts for both employers and account holders, emphasizing user-friendly platforms and 24/7 customer service. The company has also been actively working on partnerships and acquisitions to broaden its service capabilities and market reach, thereby consolidating its position as a leader in health account solutions in the U.S.
AI+ Ask Fintel’s AI assistant about HealthEquity, Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of HealthEquity, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 76.99 MM |
| Earnings Date | |
| EPS (TTM) | 0.04 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.00 |
| ROE | 0.00 |
| ROIC | 0.00 |
| CROIC | 0.05 |
| OCROIC | 0.06 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for HealthEquity, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-09-03 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-09-03 | Jefferies | Buy | Buy | Maintains |
| 2025-09-03 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-09-03 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-03-19 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-03-14 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-02-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-02-25 | Raymond James | Outperform | Outperform | Maintains |
| 2024-12-10 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-12-10 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-12-04 | Mizuho | Outperform | Initiate | |
| 2024-12-02 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-11-15 | Goldman Sachs | Neutral | Initiate | |
| 2024-11-14 | BTIG | Buy | Buy | Maintains |
| 2024-11-13 | B of A Securities | Buy | Buy | Maintains |
| 2024-09-20 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-09-04 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-09-04 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2024-09-04 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-09-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-09-04 | B of A Securities | Buy | Buy | Maintains |
| 2024-08-30 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-07-03 | B of A Securities | Buy | Buy | Maintains |
| 2024-06-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-06-07 | Raymond James | Outperform | Outperform | Maintains |
| 2024-06-05 | Keybanc | Overweight | Overweight | Maintains |
| 2024-06-04 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-06-04 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-06-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-06-04 | B of A Securities | Buy | Buy | Maintains |
| 2024-06-04 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-06-04 | Baird | Outperform | Outperform | Maintains |
| 2024-04-04 | JMP Securities | Market Outperform | Initiate | |
| 2024-04-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-03-22 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-03-22 | Keybanc | Overweight | Overweight | Maintains |
| 2024-03-20 | BTIG | Buy | Buy | Maintains |
| 2024-03-20 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-03-20 | B of A Securities | Buy | Buy | Maintains |
| 2024-02-23 | Barclays | Overweight | Overweight | Maintains |
| 2024-02-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-12-13 | Raymond James | Outperform | Outperform | Maintains |
| 2023-12-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-12-04 | Barrington Research | Outperform | Outperform | Reiterate |
| 2023-12-01 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-09-21 | Baird | Neutral | Outperform | Upgrade |
| 2023-09-07 | Deutsche Bank | Buy | Buy | Maintains |
| 2023-09-06 | Barrington Research | Outperform | Outperform | Reiterate |
| 2023-09-06 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-06-07 | Deutsche Bank | Buy | Buy | Maintains |
| 2023-06-06 | RBC Capital | Outperform | Reiterate | |
| 2023-06-01 | Barrington Research | Outperform | Outperform | Reiterate |
| 2023-03-24 | Deutsche Bank | Buy | Maintains | |
| 2023-03-22 | Barrington Research | Outperform | Reiterate | |
| 2023-03-22 | RBC Capital | Outperform | Reiterate | |
| 2023-02-03 | Wells Fargo | Overweight | Maintains | |
| 2023-01-24 | Deutsche Bank | Buy | Maintains | |
| 2022-12-12 | Raymond James | Outperform | Maintains | |
| 2022-12-07 | Guggenheim | Buy | Maintains | |
| 2022-12-07 | Wells Fargo | Overweight | Maintains | |
| 2022-12-05 | RBC Capital | Outperform | Maintains | |
| 2022-10-25 | Wells Fargo | Overweight | Maintains | |
| 2022-10-21 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2022-09-16 | Keybanc | Overweight | Initiate | |
| 2022-09-13 | Wells Fargo | Overweight | Maintains | |
| 2022-09-12 | Raymond James | Outperform | Maintains | |
| 2022-09-08 | Deutsche Bank | Buy | Maintains | |
| 2022-09-07 | Baird | Neutral | Maintains | |
| 2022-07-12 | Goldman Sachs | Sell | Initiate | |
| 2022-06-08 | Deutsche Bank | Buy | Maintains | |
| 2022-06-07 | SVB Leerink | Outperform | Maintains | |
| 2022-04-11 | Wells Fargo | Overweight | Initiate | |
| 2022-04-07 | Guggenheim | Buy | Initiate | |
| 2022-03-30 | BTIG | Neutral | Buy | Upgrade |
| 2022-03-28 | Jefferies | Buy | Maintains | |
| 2022-03-24 | Deutsche Bank | Buy | Maintains | |
| 2022-02-24 | Deutsche Bank | Buy | Maintains | |
| 2021-12-21 | JP Morgan | Overweight | Maintains | |
| 2021-12-08 | Deutsche Bank | Buy | Maintains | |
| 2021-12-07 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2021-12-07 | RBC Capital | Outperform | Maintains | |
| 2021-12-02 | Jefferies | Buy | Initiate | |
| 2021-09-21 | Deutsche Bank | Buy | Maintains | |
| 2021-09-09 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2021-07-02 | Stephens & Co. | Overweight | Initiate | |
| 2021-06-10 | Raymond James | Strong Buy | Maintains | |
| 2021-06-08 | Cantor Fitzgerald | Overweight | Maintains | |
| 2021-03-22 | Raymond James | Strong Buy | Maintains | |
| 2021-03-17 | Deutsche Bank | Buy | Maintains | |
| 2021-03-16 | SVB Leerink | Market Perform | Maintains | |
| 2021-02-10 | Raymond James | Strong Buy | Maintains | |
| 2021-02-09 | RBC Capital | Outperform | Maintains | |
| 2021-01-07 | BTIG | Neutral | Initiate | |
| 2020-12-02 | SVB Leerink | Market Perform | Maintains | |
| 2020-12-02 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2020-11-23 | Guggenheim | Buy | Neutral | Downgrade |
| 2020-10-23 | RBC Capital | Outperform | Initiate | |
| 2020-09-09 | Wells Fargo | Overweight | Maintains | |
| 2020-09-09 | SVB Leerink | Market Perform | Maintains | |
| 2020-06-03 | Cantor Fitzgerald | Overweight | Maintains | |
| 2020-04-14 | Guggenheim | Buy | Initiate | |
| 2020-04-08 | Raymond James | Strong Buy | Reiterate | |
| 2020-03-27 | Raymond James | Strong Buy | Maintains | |
| 2020-03-26 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-03-18 | Deutsche Bank | Buy | Maintains | |
| 2020-03-17 | KeyBanc | Overweight | Maintains | |
| 2020-03-17 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-03-17 | Baird | Neutral | Maintains | |
| 2020-03-17 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-02-20 | Deutsche Bank | Buy | Maintains | |
| 2020-02-19 | Wells Fargo | Overweight | Maintains | |
| 2020-02-19 | KeyBanc | Overweight | Maintains | |
| 2020-01-08 | Wells Fargo | Overweight | Maintains | |
| 2019-12-04 | KeyBanc | Overweight | Maintains | |
| 2019-10-07 | Goldman Sachs | Neutral | Initiate | |
| 2019-09-17 | KeyBanc | Overweight | Maintains | |
| 2019-09-12 | Deutsche Bank | Buy | Initiate | |
| 2019-09-09 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2019-09-04 | Oppenheimer | Outperform | Maintains | |
| 2019-09-04 | Wells Fargo | Outperformer | Maintains | |
| 2019-07-19 | Bank of America | Neutral | Buy | Upgrade |
| 2019-06-10 | Raymond James | Outperform | Reiterate | |
| 2019-03-19 | Bank of America | Neutral | Neutral | Maintains |
| 2019-03-19 | KeyBanc | Overweight | Overweight | Maintains |
| 2019-02-07 | SunTrust Robinson Humphrey | Hold | Buy | Upgrade |
| 2018-12-18 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
| 2018-12-07 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-12-06 | SunTrust Robinson Humphrey | Buy | Hold | Downgrade |
| 2018-12-06 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-09-10 | Raymond James | Outperform | Outperform | Maintains |
| 2018-09-06 | Bank of America | Buy | Neutral | Downgrade |
| 2018-09-05 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-09-05 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-09-04 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-06-05 | Baird | Neutral | Neutral | Maintains |
| 2018-06-05 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-06-05 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-05-31 | Cantor Fitzgerald | Overweight | Neutral | Downgrade |
| 2018-04-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-04-05 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-03-20 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-03-20 | Oppenheimer | Outperform | Outperform | Maintains |
| 2018-03-20 | Baird | Neutral | Neutral | Maintains |
| 2018-03-20 | Chardan Capital | Buy | Buy | Maintains |
| 2018-02-07 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2018-02-07 | Baird | Neutral | Neutral | Maintains |
| 2018-01-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2017-03-31 | Cantor Fitzgerald | Overweight | Initiate | |
| 2017-03-22 | Chardan Capital | Buy | Reiterate | |
| 2017-02-07 | Chardan Capital | Buy | Initiate | |
| 2017-01-23 | KeyBanc | Overweight | Initiate | |
| 2016-12-13 | Chardan Capital | Buy | Initiate | |
| 2016-09-12 | Raymond James | Outperform | Maintains | |
| 2016-09-07 | Baird | Neutral | Maintains | |
| 2016-06-08 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2016-04-04 | Leerink Swann | Outperform | Maintains | |
| 2016-03-23 | Avondale Partners | Market Outperform | Maintains | |
| 2016-03-23 | Barrington Research | Outperform | Maintains | |
| 2016-01-25 | Leerink Swann | Outperform | Maintains | |
| 2015-08-17 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2015-07-08 | Leerink Swann | Outperform | Maintains | |
| 2015-06-09 | Baird | Neutral | Maintains | |
| 2015-03-25 | Leerink Swann | Outperform | Maintains | |
| 2015-03-25 | JP Morgan | Overweight | Maintains | |
| 2015-03-06 | Leerink Swann | Outperform | Initiate | |
| 2015-02-19 | Barrington Research | Outperform | Initiate | |
| 2014-08-25 | JP Morgan | Outperform | Initiate | |
| 2014-08-25 | SunTrust Robinson Humphrey | Overweight | Initiate | |
| 2014-08-25 | Raymond James | Outperform | Initiate | |
| 2014-08-25 | Wells Fargo | Outperform | Initiate | |
| 2025-07-08 | Raymond James | Strong Buy | Strong Buy | Reiterate |
| 2025-03-27 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-03-25 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2025-03-24 | Keybanc | Overweight | Overweight | Maintains |
| 2025-04-11 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-04-16 | Keybanc | Overweight | Overweight | Maintains |
| 2025-08-28 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-04 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-06-04 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-04 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2025-06-04 | B of A Securities | Buy | Buy | Maintains |
| 2025-08-29 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-06-05 | Deutsche Bank | Buy | Buy | Maintains |
| 2025-06-05 | Barrington Research | Outperform | Outperform | Maintains |
